Table 2.
Dosing | |
---|---|
Case 1. Guided by INR monitoring only (Fig. 4A) | |
Day 1 | 0 mg |
Day 2 | 5 mg |
Day 3 | 7.5 mg |
Days 4–9 | 5 mg |
Days 10–16 | 5 mg |
Days 17–22 | Alternating: 5 and 2.5 mg |
Days 23–48 | 3 mg |
Days 49–90 | Alternating: 3, 3, and 5 mg |
Case 2. Guided by INR monitoring and genotype (Fig. 4B) | |
Day 1 | 5 mg |
Days 2–3 | 6 mg |
Days 4–8 | 7 mg |
Days 9–22 | 7 mg |